Split-dose protocols for semaglutide, tirzepatide, and retatrutide. Daily, twice-weekly, and three-times-weekly options.
Standard semaglutide is dosed once weekly at 0.25, 0.5, 1.0, 1.7, or 2.4 mg. Microdosing splits these into smaller, more frequent injections.
Split your weekly dose in half, inject every 3-4 days. e.g. 0.5 mg/wk → 0.25 mg twice weekly. Smoother levels, similar weekly mg.
Split into thirds, inject Mon/Wed/Fri. e.g. 1.0 mg/wk → 0.33 mg 3×/wk. Even smoother levels.
Divide weekly dose by 7. e.g. 0.7 mg/wk → 0.1 mg daily. Maximally smooth — effectively eliminates peak/trough swings. Most syringe-handling overhead.
Standard tirzepatide is once weekly at 2.5, 5, 7.5, 10, 12.5, or 15 mg.
e.g. 5 mg/wk → 2.5 mg twice weekly. Common for users sensitive to GI side effects.
e.g. 7.5 mg/wk → 2.5 mg 3×/wk. Good for higher-dose tirzepatide users wanting consistency.
Retatrutide is experimental (Phase 3) — typical research doses are 1-12 mg weekly.
e.g. 2 mg/wk → 1 mg twice weekly. Recommended for retatrutide because of its triple-agonist intensity.
Enter your vial mg, BAC water, and microdose to get the exact mL and syringe units.
Open Calculator →